Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Denmark
/
Healthcare
Create a narrative
Embla Medical hf
CPSE:EMBLA Community
1
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
Embla Medical hf
Popular
Undervalued
Overvalued
Embla Medical hf
WA
Analyst Price Target
Consensus Narrative from 5 Analysts
Acquisition Of Fior & Gentz And New Product Launches Will Expand Neuro Orthotics Portfolio Into New Markets
Key Takeaways Expansion into new markets with Fior & Gentz acquisition could boost revenue and market share through neuro orthotics. Cost reduction initiatives and share buyback may enhance profitability and improve shareholder value.
View narrative
DKK 39.12
FV
16.7% undervalued
intrinsic discount
7.48%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
12 days ago
author updated this narrative
Your Valuation for
EMBLA
Embla Medical hf
Your Fair Value
DKK
Current Price
DKK 32.60
1.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
1b
2015
2018
2021
2024
2025
2027
2030
Revenue US$1.2b
Earnings US$96.7m
Advanced
Set as Fair Value